Diff Profiles › MTBLS1188_0001_00000002

IFN_responder_Pre-infection_vs_Diagnosis

IFN_responder_Pre-infection vs IFN_responder_Diagnosis

p-value ≤ 0.05 9 significant 2025-09-26 00:00:00 Study: MTBLS1188
10 Total Features
9 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS1188_0001_00000002
Linked study
MTBLS1188 — Immune variation leads to diverse outcomes in human malaria
Comparison
IFN_responder_Pre-infection vs IFN_responder_Diagnosis
Group A
IFN responders at pre-infection time point. Provides baseline data for IFN responders before infection.
Group B
IFN responders at diagnosis time point. Provides data on IFN responders at the time of clinical diagnosis.
Total features tested
10
Significant features
9
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
UUDAMDVQRQNNHZ-UHFFFAOYSA-N (S)-AMPA up 6.975 0.000709
WXSKVKPSMAHCSG-UHFFFAOYSA-N 4-Hydroxy-2-oxoglutaric acid up 25.15 0.0158
SUHOQUVVVLNYQR-MRVPVSSYSA-N sn-glycero-3-phosphocholine up 5.25 0.0181
OIRDTQYFTABQOQ-KQYNXXCUSA-N Adenosin down 0.2107 0.014
OEYIOHPDSNJKLS-UHFFFAOYSA-N Choline up 2.6 0.0021
IHNKQIMGVNPMTC-RUZDIDTESA-N Lysophosphatidylcholine(18:0) up 2.798 0.0058
LEVWYRKDKASIDU-IMJSIDKUSA-N (2<i>R</i>,2'<i>R</i>)-3,3'-dithiobis(2-ammoniopropanoate) down 0.4389 0.00732
DSLZVSRJTYRBFB-LLEIAEIESA-N saccharic acid up 2.11 0.00866
ZHRLECIZINSPKL-AKGZTFGVSA-N Cystinyl-GLY down 0.6235 0.0361